Metropolis Healthcare Stock Screener | Share Price & Fundamental Analysis
METROPOLIS
Healthcare Service Provider
Share Price NSE
₹1860.10
▼
-39.30 (-2.07%)
Share Price BSE
₹1864.70
▼
-33.70 (-1.78%)
Track Metropolis Healthcare share price live with TickJournal's free stock screener.
Analyze Metropolis Healthcare share price history trends and compare 52-week high low
levels.
Calculate METROPOLIS stock fair value using fundamental analysis and view live share price charts.
Determine Metropolis Healthcare share intrinsic value and compare it with current METROPOLIS share price.
Record your Metropolis Healthcare trades in TickJournal's free trading journal and track your portfolio performance.
Metropolis Healthcare Market Cap
₹9,978.32 Cr.
EPS (TTM)
₹28.29
Dividend Yield
-
Debt to Equity
0.17
METROPOLIS 52 Week High
₹2240.00
Metropolis Healthcare 52 Week Low
₹1488.60
Operating Margin
18.00%
Profit Margin
8.24%
METROPOLIS Revenue (TTM)
₹352.00
EBITDA
₹69.00
Net Income
₹29.00
Total Assets
₹1,867.00
Total Equity
₹1,335.00
Metropolis Healthcare Share Price History - Stock Screener Chart
Screen METROPOLIS historical share price movements with interactive charts. Analyze price trends and patterns.
Metropolis Healthcare Company Profile - Fundamental Screener
Screen Metropolis Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for METROPOLIS shares.
Metropolis Healthcare Limited is an Indian diagnostic services company operating across India and Africa. Founded in 1980 as a pathology partnership, it has evolved into a public company offering a wide range of clinical laboratory tests and profiles. The company operates through a hub and spoke model with 115 clinical...more
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
Chairperson/CEO
Ameera Sushil Shah
ISIN
INE112L01020
Website
https://www.metropolisindia.com
Metropolis Healthcare Balance Sheet Screener
Screen METROPOLIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 1,867 | 1,555 | 1,502 | 1,530 | 1,004 | 752 | 553 | 530 |
| Current Assets | 346 | 316 | 303 | 393 | 609 | 397 | 305 | 300 |
| Fixed Assets | 1,447 | 1,177 | 1,121 | 1,059 | 343 | 296 | 213 | 207 |
| Liabilities | ||||||||
| Total Liabilities | 1,867 | 1,555 | 1,502 | 1,530 | 1,004 | 752 | 553 | 530 |
| Current Liabilities | 238 | 210 | 246 | 341 | 92 | 58 | 8 | 11 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 1,335 | 1,099 | 991 | 888 | 708 | 525 | 420 | 429 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | 1,313 | 1,086 | 978 | 876 | 696 | 513 | 409 | 405 |
Metropolis Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Metropolis Healthcare income statement and profit fundamentals.
Analyze METROPOLIS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Metropolis Healthcare share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 352 | 394 | 430 | 415 | 334 | 316 | 353 | 325 | 284 | 280 | 310 | 293 | 312 | 283 | 305 |
| Expenses | 283 | 296 | 321 | 320 | 251 | 235 | 260 | 251 | 212 | 214 | 234 | 226 | 231 | 211 | 221 |
| EBITDA | 69 | 97 | 109 | 95 | 83 | 81 | 93 | 75 | 72 | 66 | 76 | 67 | 81 | 72 | 83 |
| Operating Profit % | 18.00% | 23.00% | 25.00% | 21.00% | 24.00% | 25.00% | 26.00% | 22.00% | 25.00% | 23.00% | 24.00% | 22.00% | 24.00% | 24.00% | 26.00% |
| Depreciation | 29 | 31 | 32 | 32 | 26 | 26 | 27 | 28 | 23 | 21 | 22 | 25 | 18 | 21 | 22 |
| Interest | 5 | 5 | 6 | 6 | 6 | 5 | 5 | 5 | 6 | 6 | 6 | 5 | 6 | 8 | 7 |
| Profit Before Tax | 36 | 61 | 71 | 57 | 51 | 51 | 61 | 42 | 42 | 39 | 48 | 37 | 57 | 43 | 55 |
| Tax | 7 | 16 | 18 | 15 | 14 | 13 | 15 | 11 | 8 | 10 | 13 | 10 | 16 | 9 | 14 |
| Net Profit | 29 | 45 | 53 | 42 | 37 | 38 | 47 | 32 | 34 | 29 | 36 | 27 | 40 | 34 | 41 |
| EPS | 5.69 | 8.70 | 10.17 | 7.99 | 7.11 | 7.41 | 9.08 | 6.12 | 6.51 | 5.62 | 6.92 | 5.30 | 7.81 | 6.53 | 7.88 |
Metropolis Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen METROPOLIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 263 | 264 | 247 | 253 | 249 | 215 | 90 | 104 | 102 | 91 |
| Investing Activities | -199 | -89 | 48 | -736 | 63 | -104 | 36 | 1 | -86 | 96 |
| Financing Activities | -87 | -181 | -292 | 163 | -33 | -55 | -118 | -87 | -17 | -174 |
| Net Cash Flow | -23 | -6 | 3 | -321 | 279 | 56 | 8 | 18 | -1 | 14 |
Metropolis Healthcare Shareholding Pattern Screener
See Metropolis Healthcare shareholding pattern with promoter, FII, and DII holdings.
Check Metropolis Healthcare promoter holding and ownership changes for METROPOLIS on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 48.90% | 48.89% | 48.89% | 48.88% | 49.67% | 49.62% | 49.43% | 49.40% |
| FII Holding | 15.29% | 12.83% | 12.52% | 11.69% | 18.90% | 18.25% | 18.56% | 16.73% |
| DII Holding | 30.30% | 32.40% | 33.10% | 34.73% | 24.86% | 27.43% | 28.02% | 30.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 3.84% | 4.16% | 3.69% | 3.87% | 5.24% | 4.07% | 3.54% | 3.34% |
| Other Holding | 1.68% | 1.72% | 1.80% | 0.83% | 1.33% | 0.63% | 0.45% | 0.53% |
| Shareholder Count | 49,293 | 50,015 | 47,846 | 46,670 | 68,283 | 58,108 | 51,852 | 48,572 |
Metropolis Healthcare Share Dividend Screener - Share Yield Analysis
Check Metropolis Healthcare dividend history with payout and yield data.
View Metropolis Healthcare dividend details including ex-dates and amounts for METROPOLIS stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹4.00 | 0.26% |
| 2023-March | ₹8.00 | 0.46% |
| 2022-March | ₹8.00 | 0.67% |
| 2021-March | ₹8.00 | 0.39% |
| 2020-March | ₹8.00 | 0.36% |
| 2019-March | ₹13.26 | 1.03% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Metropolis Healthcare Stock Index Membership
See which indices include Metropolis Healthcare stock.
Check METROPOLIS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Metropolis Healthcare Market Events Screener - Corporate Actions
Get Metropolis Healthcare corporate actions including splits, bonuses, and buybacks.
Check Metropolis Healthcare stock events that may affect METROPOLIS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-04 | 2026-02-04 | Quarterly Result Announcement | NA | 5.61% |
| 2025-11-11 | 2025-11-11 | Dividend | ₹ 4.00 /share | -3.41% |
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | 2.62% |
| 2025-08-13 | 2025-08-13 | Annual General Meeting | NA | 7.95% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 1.82% |
| 2025-05-13 | 2025-05-13 | Quarterly Result Announcement | NA | 1.03% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | 2.86% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | -0.31% |
| 2024-08-21 | 2024-08-21 | Annual General Meeting | NA | -0.32% |
| 2023-11-17 | 2023-11-17 | Dividend | ₹ 4.00 /share | 9.14% |
| 2023-02-23 | 2023-02-23 | Dividend | ₹ 8.00 /share | 4.60% |
| 2022-02-21 | 2022-02-22 | Dividend | ₹ 8.00 /share | -19.67% |
| 2021-02-17 | 2021-02-19 | Dividend | ₹ 8.00 /share | -7.01% |
Metropolis Healthcare Competitors Screener - Peer Comparison
Screen METROPOLIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 23,990 | 43.99 | 2,555 | 11.28% | 492 | 43.51 |
| Vijaya Diagnostic Centre | 10,412 | 66.85 | 700 | 23.06% | 144 | 49.38 |
| Metropolis Healthcare | 9,978 | 59.56 | 1,346 | 10.64% | 146 | 52.68 |
| Thyrocare Technologies | 6,468 | 47.28 | 702 | 20.80% | 91 | 38.76 |
| Nephrocare Health Services | 5,649 | 80.72 | 770 | 33.97% | 67 | 69.85 |
| Krsnaa Diagnostics | 2,153 | 26.93 | 743 | 16.70% | 78 | 34.08 |
| One Global Service Provider | 1,534 | 33.25 | 148 | 134.60% | 19 | 73.28 |
| Suraksha Diagnostic | 1,484 | 45.68 | 256 | 15.11% | 31 | 60.68 |
| 3B BlackBio DX | 1,382 | 23.52 | 112 | 28.72% | 48 | 50.92 |
| Sastasundar Ventures | 935 | 32.12 | 1,171 | -18.47% | -134 | 45.34 |
Metropolis Healthcare Company Announcements - News Screener
Screen METROPOLIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-18 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-13 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Restructuring | View |
| 2026-02-04 | Corporate Action-Board recommends Bonus Issue | View |
| 2026-02-04 | Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025 | View |
| 2026-02-04 | Board Meeting Outcome for The Meeting Held Today (February 04 2026) | View |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-30 | Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025 And Issuance Of Bonus Shares | View |
| 2026-01-13 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2026-01-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-05 | Business Update For Q3FY26 | View |
| 2025-12-31 | Closure of Trading Window | View |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |